Your browser doesn't support javascript.
loading
VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer.
Chionh, Fiona; Gebski, Val; Al-Obaidi, Sheren J; Mooi, Jennifer K; Bruhn, Maressa A; Lee, Chee K; Chüeh, Anderly C; Williams, David S; Weickhardt, Andrew J; Wilson, Kate; Scott, Andrew M; Simes, John; Hardingham, Jennifer E; Price, Timothy J; Mariadason, John M; Tebbutt, Niall C.
Afiliación
  • Chionh F; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia.
  • Gebski V; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, 2006, Australia.
  • Al-Obaidi SJ; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia.
  • Mooi JK; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia.
  • Bruhn MA; Haematology-Oncology Department, Basil Hetzel Institute, The Queen Elizabeth Hospital, Woodville, SA, 5001, Australia.
  • Lee CK; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, 2006, Australia.
  • Chüeh AC; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia.
  • Williams DS; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VIC, 3084, Australia.
  • Weickhardt AJ; Cancer Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, 3168, Australia.
  • Wilson K; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia.
  • Scott AM; School of Cancer Medicine, La Trobe University, Bundoora, VIC, 3086, Australia.
  • Simes J; Department of Pathology, Austin Health, Heidelberg, VIC, 3084, Australia.
  • Hardingham JE; Department of Clinical Pathology, The University of Melbourne, Parkville, VIC, 3010, Australia.
  • Price TJ; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia.
  • Mariadason JM; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, 2006, Australia.
  • Tebbutt NC; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia.
Sci Rep ; 12(1): 1238, 2022 01 24.
Article en En | MEDLINE | ID: mdl-35075138
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma / Neoplasias Colorrectales / Receptores de Factores de Crecimiento Endotelial Vascular / Factor A de Crecimiento Endotelial Vascular / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma / Neoplasias Colorrectales / Receptores de Factores de Crecimiento Endotelial Vascular / Factor A de Crecimiento Endotelial Vascular / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido